We are live on
!
Find out more
SCM
Sio Capital Management Portfolio holdings
AUM
$694M
1-Year Est. Return
79.73%
This Fund
S&P 500
This Quarter
Est. Return
-2.52%
1 Year Est. Return
+79.73%
3 Year Est. Return
+576.62%
5 Year Est. Return
+422.76%
10 Year Est. Return
+2,506.65%
AUM
$132M
AUM Growth
-$95.9M
(-42%)
Cap. Flow
-$87.5M
Cap. Flow
% of AUM
-66.19%
Top 10 Holdings %
Top 10 Hldgs %
71.81%
Holding
61
New
12
Increased
4
Reduced
14
Closed
17
Top Buys
| 1 |
Biogen
BIIB
|
+$16.1M |
| 2 |
Medtronic
MDT
|
+$6.07M |
| 3 |
HRC
HILL-ROM HOLDINGS, INC.
HRC
|
+$4.21M |
| 4 |
Abbott
ABT
|
+$4.16M |
| 5 |
Cardinal Health
CAH
|
+$2.85M |
Top Sells
| 1 |
McKesson
MCK
|
+$12.9M |
| 2 |
SHPG
Shire pic
SHPG
|
+$10.9M |
| 3 |
Eli Lilly
LLY
|
+$10.1M |
| 4 |
Alnylam Pharmaceuticals
ALNY
|
+$9.65M |
| 5 |
AGN
Allergan plc
AGN
|
+$9.63M |
Sector Composition
| 1 | Healthcare | 88.82% |
| 2 | Industrials | 1.93% |
| 3 | Consumer Discretionary | 0.92% |
| 4 | Materials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
QTNT
1
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $18.1M | 13.67% |
58,346
-983
| -2% | -$375K |
|
|
2
Biogen
BIIB
$28.1B
| $14.8M | 11.15% |
+61,000
| New | +$16.1M |
|
|
3
Cardinal Health
CAH
$53.4B
| $13.3M | 10.05% |
170,404
+35,771
| +27% | +$2.85M |
|
4
Philips
PHG
$26B
| $8.59M | 6.49% |
464,872
+73,298
| +19% | +$1.42M |
|
5
Sanofi
SNY
$104B
| $8.37M | 6.33% |
200,000
-4,655
| -2% | -$191K |
|
|
NEOS
6
DELISTED
Neos Therapeutics, Inc
NEOS
| $7.86M | 5.94% |
847,127
-442,896
| -34% | -$4.22M |
|
|
ANTH
7
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
| $7.83M | 5.92% |
316,946
-65,079
| -17% | -$1.84M |
|
|
8
Medtronic
MDT
$103B
| $6.51M | 4.92% |
+75,000
| New | +$6.07M |
|
9
Amgen
AMGN
$193B
| $5.48M | 4.14% |
36,000
-41,721
| -54% | -$6.49M |
|
|
HRC
10
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $4.22M | 3.19% |
+83,600
| New | +$4.21M |
|
|
11
Abbott
ABT
$155B
| $4.11M | 3.11% |
+104,550
| New | +$4.16M |
|
12
Rigel Pharmaceuticals
RIGL
$753M
| $2.97M | 2.25% |
133,370
-28,320
| -18% | -$704K |
|
|
CCXI
13
DELISTED
ChemoCentryx, Inc.
CCXI
| $2.89M | 2.18% |
+642,828
| New | +$2.41M |
|
|
AAAP
14
DELISTED
Advanced Accelerator Applications S.A.
AAAP
| $2.85M | 2.15% |
94,177
-79,824
| -46% | -$2.54M |
|
15
Bristol-Myers Squibb
BMY
$120B
| $2.75M | 2.08% |
+37,419
| New | +$2.64M |
|
16
Ascendis Pharma A/S
ASND
$17.2B
| $2.69M | 2.03% |
202,520
+15,300
| +8% | +$236K |
|
|
FOMX
17
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $2.57M | 1.95% |
405,374
-167,254
| -29% | -$1.11M |
|
18
TriNet
TNET
$2.66B
| $2.55M | 1.93% |
122,563
-191,112
| -61% | -$3.5M |
|
|
FWP
19
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
| $2.26M | 1.71% |
17,782
-13,133
| -42% | -$1.77M |
|
|
DMK
20
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
| $1.92M | 1.45% |
9,778
-8,255
| -46% | -$3.81M |
|
|
21
McKesson
MCK
$94.3B
| $1.87M | 1.41% |
10,000
-73,600
| -88% | -$12.9M |
|
22
IQVIA
IQV
$35B
| $1.86M | 1.41% |
+28,541
| New | +$1.91M |
|
|
AFAM
23
DELISTED
Almost Family Inc
AFAM
| $1.21M | 0.92% |
+28,452
| New | +$1.17M |
|
|
ADMS
24
DELISTED
Adamas Pharmaceuticals
ADMS
| $855K | 0.65% |
56,500
+36,500
| +183% | +$602K |
|
|
MTEM
25
DELISTED
Molecular Templates, Inc.
MTEM
| $847K | 0.64% |
8,082
-15,871
| -66% | -$1.14M |
|
Similar funds
IIC
MCM
CGIC
HA
BBPWM
M
HG
CA